Bio-Rad has entered a binding offer to purchase all equity interests in French biotech Stilla Technologies. According to ...

Given the large stake in the stock by institutions, Qiagen's stock price might be vulnerable to their trading decisions 51% of the business is held by the top 18 shareholders Using data from analyst ...

QIAGEN has announced the official opening of a new data center in Melbourne, Australia, designed to strengthen its global bioinformatics leadership position in this region of the world.

In a report released on February 13, Maja Pataki from Kepler Capital maintained a Hold rating on Alcon (ALC – Research Report), with a price ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...